• Skip to Content
  • Skip to Main Navigation
  • Skip to Information Links
  • Skip to Site Search
  • Skip to Footer
  • Skip to Accessibility Information
  • Home Page

This site is intended for healthcare professionals

Information Links

  • Sign in
  • Register
  • Subscribe
  • Free Trial
  • Submit product update

Mims Home button

Menu

Main Navigation

  • News
  • Tables (46)
  • Trackers (7)
  • Guidelines (22)
  • Clinics
  • Visual Guides
  • Events
Click to search or browse MIMS
  • Drugs
  • Conditions
  • News and resources
  • MIMS Supported Resources

Last updated: 08 December 2023

Browse 3000+ drugs by disease Browse drugs by 500+ manufacturers

Browse news and resources by disease area

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse all
Search Help

  • Trending trending icon
  • Methylphenidate
  • Wegovy
  • Drug shortages
  • HRT table

Cancer and palliative care news

  • Hormone treatment approved for breast cancer prevention

  • Methotrexate sun protection reminder after patient death

  • Offer home tests to all patients with colorectal cancer symptoms, NICE advises

  • NICE approves breast cancer drug as first women's health strategy launched

  • Free MIMS Learning webinar: explaining genomic profiling results in breast cancer

  • Free MIMS Learning webinar on genomic testing to guide cancer treatment

  • MST Continus granules to be discontinued

  • New contraindication for co-cyprindiol

  • GPs warned over unsafe methotrexate prescribing

  • Boys to be vaccinated against HPV from September

  • Vitamin D and omega-3 do not prevent cancer or cardiovascular disease, major trial suggests

  • Doctors identify 50 'unnecessary' medical interventions

  • Help cancer patients live longer by offering smoking cessation support, GPs urged

  • Rolapitant: a new option for chemotherapy-induced nausea and vomiting

  • Infographic: Breast cancer prevention drug underused in primary care

  • Once-daily modified-release oxycodone launched

  • Rituximab biosimilar launched in UK

  • New myeloma treatment provides all-oral regimen option

  • Ibrutinib gains NICE approval for use in CLL

  • NICE approves drugs for NSCLC and multiple myeloma

More


  • Advertising and Sponsorship
  • Contact us
  • Editorial Complaint
  • FAQs
  • About us
  • For pharma
  • Sign in
  • Register
  • Free Trial
  • Submit product update
Haymarket © Haymarket Media Group Ltd. | Terms & Conditions | Cookie Notice | Privacy Notice| Cookie Settings
IPSO